Who Paid My Doc
Kenneth Champagne
Colon & Rectal Surgery Lafayette, LA Medical Doctor
NPI 1740284454 CMS profile 1209847
102 Drury Ln, Lafayette, LA 70508
General payments
$235
Research payments
$0
Ownership & investment interest
$0
Through program year 2024, Kenneth Champagne of Lafayette, LA is reported in the CMS Open Payments database as having received $235 across 7 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 13th percentile of Colon & Rectal Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $25 | 1 | |
| 2023 | General | $33 | 1 | |
| 2022 | General | $75 | 3 | |
| 2021 | General | $87 | 1 | |
| 2019 | General | $14 | 1 |
Beside peers
- Kenneth Champagne
- Colon & Rectal Surgery median
- Middle half of Colon & Rectal Surgery
- National median
In program year 2025, general payments to Kenneth Champagne were reported at $0. Among 1,481 Colon & Rectal Surgery profiles paid that year, the median was $317 and the middle half received between $109 and $1,248.
Show as a table
| Year | Kenneth Champagne | Colon & Rectal Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $14 | $443 | $125–$2,179 | $163 |
| 2020 | $0 | $167 | $53–$931 | $114 |
| 2021 | $87 | $207 | $72–$1,272 | $132 |
| 2022 | $75 | $341 | $111–$1,587 | $149 |
| 2023 | $33 | $322 | $115–$1,420 | $160 |
| 2024 | $25 | $328 | $112–$1,354 | $164 |
| 2025 | $0 | $317 | $109–$1,248 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 22 billing codesPaid by Medicare
$32,150
Medicare patients
193
Services billed
275
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 39% | |
| Ischemic heart disease | 33% | |
| Diabetes | 24% | |
| Cancer | 17% | |
| Osteoporosis | 17% | |
| Atrial fibrillation | 16% | |
| Depression | 14% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
7 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Colon & Rectal Surgery in Louisiana
Jennifer Paruch
Colon & Rectal Surgery · New Orleans, LA
Andrew Werner
Colon & Rectal Surgery · Shreveport, LA
Charles Whitlow
Colon & Rectal Surgery · New Orleans, LA
Brielle Hebert
Colon & Rectal Surgery · Shreveport, LA
Jennifer Silinsky
Colon & Rectal Surgery · Metairie, LA
Elyse Bevier-Rawls
Colon & Rectal Surgery · New Orleans, LA
Related records
Colon & Rectal Surgery in Louisiana
Practitioners in the same specialty and state, ranked by reported value.
All Colon & Rectal Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Louisiana
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.